Science

Fruit fly sleep protein yields peptides that inhibit drug-resistant bacteria in lab tests

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 13/11/2026, 19:40:24 UTC.

Briefings

Researchers at the University of Tsukuba and collaborating institutions identified short antimicrobial peptides derived from Nemuri, a sleep-inducing protein in the fruit fly Drosophila melanogaster. The findings were published in the journal Nature Communications, marking a significant step in understanding how sleep-related proteins can influence bacterial defense mechanisms.

Key points

• Researchers at the University of Tsukuba identified short antimicrobial peptides derived from Nemuri, a sleep-inducing protein in the fruit fly Drosophila melanogaster.
• The peptides were successfully tested in lab settings against drug-resistant bacteria, demonstrating potential applications in medical research.

Context

This research represents a novel approach to antimicrobial therapy by leveraging sleep-related proteins from model organisms. The findings are significant for future medical applications as they suggest a new avenue for developing treatments against resistant pathogens.

Limitations

The evidence is limited to laboratory tests conducted by researchers at the University of Tsukuba and collaborating institutions. The specific bacterial strains tested are not named, and the long-term efficacy of the peptides in human clinical trials remains untested.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 13/11/2026, 19:41:52 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiblxwx7ygh5iacmvloqvirsd6zv7egnrd2j2whrflozpogtu2hrdy